EUVIMEDEUVIMED entdecken
Open Access

Estimated Medicaid Spending on Original and Citrate-Free Adalimumab From 2014 Through 2021

Junyi Wang, ChangWon C Lee, Aaron S Kesselheim, Benjamin N Rome

JAMA Internal Medicine · 01.03.2023 · 183 (3) · 275

DOI: 10.1001/jamainternmed.2022.6299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Internal Medicine, erschienen am 01.03.2023. Verfasst von Junyi Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hos…. Hauptthemen laut MEDLINE: Medicaid, Citric Acid. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This cross-sectional study assesses Medicaid spending associated with citrate-free vs original adalimumab.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MedicaidCitric AcidHumansUnited StatesAdalimumabCitratesHealth Expenditures

Substanzen

AdalimumabCitric AcidCitrates

Autor:innen und Institutionen

  • Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Zitieren

APA

Wang, J., Lee, C. C., Kesselheim, A. S., & Rome, B. N. (2023). Estimated Medicaid Spending on Original and Citrate-Free Adalimumab From 2014 Through 2021. JAMA Internal Medicine, 183(3), 275. https://doi.org/10.1001/jamainternmed.2022.6299

Vancouver

Wang J, Lee CC, Kesselheim AS, Rome BN. Estimated Medicaid Spending on Original and Citrate-Free Adalimumab From 2014 Through 2021. JAMA Internal Medicine. 2023;183(3):275. doi:10.1001/jamainternmed.2022.6299

BibTeX
@article{Wang2023,
  author = {Wang, Junyi and Lee, ChangWon C and Kesselheim, Aaron S and Rome, Benjamin N},
  title = {Estimated Medicaid Spending on Original and Citrate-Free Adalimumab From 2014 Through 2021},
  journal = {JAMA Internal Medicine},
  year = {2023},
  volume = {183},
  number = {3},
  pages = {275},
  doi = {10.1001/jamainternmed.2022.6299}
}
Kostenlos starten →